Medicine and Dentistry
Cluster Randomized Trial
100%
Randomized Controlled Trial
81%
Stillbirth
77%
Fetus Mortality
75%
Awareness
75%
Traumatic Brain Injury
75%
Fetal Movement
75%
Clinical Trial
58%
Intensive Care
56%
Intensive Care Unit
56%
Apoplexy
50%
Infancy
50%
Cerebral Hemorrhage
50%
Antiplatelet
50%
Open-Label Trial
50%
Bronchiolitis
50%
Hypothermia
50%
Paracetamol
50%
Macrophage
50%
Liver Injury
50%
Erythrocyte Transfusion
50%
Anemia
50%
Care Group
44%
Pregnant Woman
42%
Intracranial Hypertension
37%
Intention-to-Treat Analysis
32%
Intracranial Pressure
32%
Oxygen Saturation
30%
Primary Outcome
29%
Analgesia
25%
Cardiac Troponin
25%
Receptor Blocking
25%
Beta Adrenergic Receptor Blocking Agent
25%
Troponin I
25%
Anthracycline
25%
Heart Left Ventricle Ejection Fraction
25%
Risk Stratification
25%
Pain Assessment
25%
Brain Imaging
25%
Malignant Neoplasm
25%
Targeted Temperature Management
25%
Cardiotoxicity
25%
Placebo
25%
Angiotensin Receptor
25%
Cerebrovascular Disease
25%
Subgroup Analysis
25%
Glycon
25%
Retina Disease
25%
Obstetrics
18%
Odds Ratio
15%
Nursing and Health Professions
Traumatic Brain Injury
81%
Intensive Care Unit
62%
Hypothermia
56%
Intensive Care
56%
Erythrocyte Transfusion
50%
Anemia
50%
Intracranial Hypertension
37%
Intracranial Pressure
34%
Body Temperature
31%
Randomization
31%
Cancer Center
25%
Receptor Blocking
25%
Angiotensin Receptor
25%
Analgesia
25%
Pain Assessment
25%
Fetus Mortality
25%
Patient Participation
25%
Patient Compliance
25%
Health Outcomes
25%
Wearables
25%
Stillbirth
25%
Co-Design
25%
Troponin I
25%
Retina Disease
25%
Anthracycline
25%
Heart Left Ventricle Ejection Fraction
25%
Cardiotoxicity
25%
Beta Adrenergic Receptor Blocking Agent
25%
Intention to Treat Analysis
23%
Core Temperature
23%
Induced Hypothermia
21%
Glasgow Outcome Scale
15%
Logistic Regression Analysis
13%
Odds Ratio
12%
Proportional Hazards Model
12%
Heart Protection
12%
Patient Attitude
10%
Troponin
9%
Oxygenation
7%
Injury Severity
6%
Head Injury
6%
Low Risk Population
6%
Outcome Assessment
6%
Breast Cancer
6%
Carvedilol
6%
Candesartan
6%
Blood Sampling
6%
Inflammation
6%
Short Form 36
6%
Weakness
6%
